Find clinical trials for Endometrial Cancer in Taipei City
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Endometrial Cancer trials near Taipei City, TWN:
Phase Ia study of Atezolizumab (NCT01375842) monotherapy in relapsed endometrial cancer were reported as abstract at ASCO 2017. Fif...
Phase 3
Taoyuan City, Taiwan and 92 other locations
drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...
Phase 1
Taipei, Taiwan and 75 other locations
choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...
Phase 3
Taipei, Beitou, Taiwan and 168 other locations
TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Com...
Phase 2
Taipei, Taiwan and 92 other locations
per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 as assessed by investigator in participants proficient in mismatch repair (pMMR) endometrial...
Phase 2
Taichung, Taiwan and 35 other locations
The purpose of this study is to compare pembrolizumab + adjuvant chemotherapy with placebo + adjuvant chemotherapy, with or without radiotherapy, wit...
Phase 3
Taipei, Taiwan and 230 other locations
ACE1702 (anti-HER2 oNK cells) is an off-the-shelf Natural Killer (NK) cell product that targets human HER2-expressing solid tumors. The ACE1702-001 p...
Phase 1
Taipei, Taiwan and 2 other locations
The primary objective of this study is to assess the safety and tolerability and to determine the recommended Phase 2 dose (RP2D) of E7386 in combina...
Phase 1
Taipei, Taiwan and 47 other locations
In this study, participants with multiple types of advanced (unresectable and/or metastatic) solid tumors who have progressed on standard of care the...
Phase 2
Taipei, Taiwan and 22 other locations
This research study is studying a new compound, AZD8205, as a possible treatment for advanced or metastatic solid tumours
Phase 1, Phase 2
Taipei, Taiwan and 52 other locations
Clinical trials
Research sites
Resources
Legal